human cancer - 드림위즈 통합검색

블로그

Lapatinib [T0078][Cas No. 231277-92-2]_TargetMol - 코아사이언스 Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer Clin Cancer Res. 2010 Mar 1;16(5):1509-19. 2.Guan M, et al. blog.naver.com · 2026.07.16
Paclitaxel-MVCP [620102][CAS no. 2119034-12-5]_MedKoo Biosciences - 코아사이언스 used in the development of antibody-drug conjugates (ADCs) and targeted drug delivery systems for cancer cancer cell li....... blog.naver.com · 2026.07.31
SB-431542 [T1726][Cas No. 301836-41-9]_TargetMol - 코아사이언스 Mol Cancer Ther. 2004 Jun;3(6):737-45. 3.Chambers SM, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMA....... blog.naver.com · 2026.07.16
Mertansine [T1992][CAS no. 139504-50-0]_TargetMol - 코아사이언스 50mg, 100mg DataSheet All TargetMol products are for research purposes only and cannot be used for human Semisynthetic maytansine analogues for the targeted treatment of cancer. blog.naver.com · 2026.08.04
High-IF Literature for Your Reference_ELK Biotechnology - 코아사이언스 52.7 Signal Transduction and Targeted Therapy DOI https://doi.org/10.1038/s41392-025-02518-y ELK1142 Human IL10(Interleukin 10) ELISA Kit ELK1790 Human ARG1(Arginase I) ELISA Kit ELK1185 Human TGFb1(Transforming blog.naver.com · 2026.06.12
Fulvestrant [T2146][Cas No. 129453-61-8]_TargetMol - 코아사이언스 Down-regulator Fulvestrant Potentiates Antitumor Activity of Fluoropyrimidine in Estrogen-responsive MCF-7 Human Breast Cancer Cells. blog.naver.com · 2026.07.16
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer , breast cancer is the most prevalent form of a malignant tumour. Among the subtypes of breast cancer, hormone receptor (HR) positive and human epidermal growth factor blog.naver.com · 2025.11.02
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients ... Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (aBC). blog.naver.com · 2025.07.07
TR #1077 - Cancer models 1077-Ayehunie_2025_Large scale in vitro expansion of primary tumors from metastasis cancer patients with Key words: colorectal tumoroids, melanoma, uterine cancer, patient derived primary tumors, human tissue blog.naver.com · 2025.06.12
Reactivating cGAS-STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS-Mutant Tumor Antitumor Immunity in NRAS-Mutant Tumors Abstract NRAS is commonly mutated in several different types of human cancer. blog.naver.com · 2025.06.03

블로그 결과 더보기 →

동영상